secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hepion Pharmaceuticals, Inc. (HEPA)
CIK:        0001583771
Form:       8-K
Filed at:   2024-09-05T23:59:59+00:00
Accession:  0001493152-24-035076
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Hepion Pharmaceuticals receives Nasdaq deficiency notice for bid price below $1.00
--------------------------------------------------------------------------------

- Notice received Sept. 3, 2024; bid price below $1.00 for 30 consecutive business days.
- Company has 180 calendar days, until March 3, 2025, to regain compliance.
- To regain compliance, closing bid must be ≥$1.00 for at least 10 consecutive business days.
- If not compliant, may qualify for a second 180-day period; otherwise Nasdaq will delist.
- Common stock continues trading on Nasdaq under symbol HEPA.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1583771/000149315224035076/0001493152-24-035076-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1583771/000149315224035076/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-035076

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer